Azithromycin Dosage and Administration Guidelines for Children

Dosage by Indication

• The American Academy of Pediatrics recommends a dosage of 10 mg/kg (maximum 500 mg) on day 1, followed by 5 mg/kg (maximum 250 mg) daily for days 2-5 for community-acquired pneumonia in children 1
• The Infectious Diseases Society of America recommends the same 5-day regimen for atypical pneumonia (Mycoplasma, Chlamydia) in children 2, 3
• The Centers for Disease Control and Prevention recommends a dosage of 10 mg/kg once daily for 5 days for pertussis treatment and post-exposure prophylaxis in infants <6 months, and 10 mg/kg (maximum 500 mg) on day 1, followed by 5 mg/kg (maximum 250 mg) daily for days 2-5 for children ≥6 months 4
• The Centers for Disease Control and Prevention recommends a dosage of 20 mg/kg body weight (maximum 1,200 mg) by mouth weekly for Mycobacterium avium complex (MAC) prophylaxis in HIV-infected children 5

Alternative Options

• The American Academy of Pediatrics recommends alternative options for children allergic to azithromycin, including clarithromycin (15 mg/kg/day in 2 doses), erythromycin (40 mg/kg/day in 4 doses), and doxycycline (for children >7 years old) 1, 2

Important Cautions

• The Centers for Disease Control and Prevention advises avoiding concurrent administration of azithromycin with aluminum- or magnesium-containing antacids, as they reduce absorption, and monitoring is advised when used with drugs metabolized by cytochrome P450 enzyme system 4

Pediatric Azithromycin Dosage Guidelines

Dosing by Weight

• For children weighing 15-25 kg, the recommended dosage is 200 mg once daily, according to the Thorax guideline society 6
• For children weighing 26-35 kg, the recommended dosage is 300 mg once daily, according to the Thorax guideline society 6
• For children weighing 36-45 kg, the recommended dosage is 400 mg once daily, according to the Thorax guideline society 6
• For children weighing 46 kg and above, the recommended dosage is 500 mg once daily, according to the Thorax guideline society 6

Safety Considerations

• Monitor for potential drug interactions, particularly with medications that prolong QT interval, as recommended by the Thorax guideline society 6

Azithromycin Use in Pediatric Patients

Age-Specific Recommendations

• The Centers for Disease Control and Prevention recommends azithromycin as the preferred macrolide for treatment and post-exposure prophylaxis of pertussis in infants under 1 month of age, with a dosage of 10 mg/kg once daily for 5 days 7
• For infants under 1 month, azithromycin has not been associated with infantile hypertrophic pyloric stenosis (IHPS), although monitoring for IHPS and other serious adverse events is recommended 7, 8
• The Centers for Disease Control and Prevention recommends azithromycin as a first-line agent for pertussis treatment and prophylaxis in infants 1-5 months, based on in vitro effectiveness, safety, and convenient dosing schedule 7, 8

Treatment of Community-Acquired Pneumonia

• The Infectious Diseases Society of America recommends a 5-day regimen of azithromycin for community-acquired pneumonia, particularly atypical pneumonia caused by Mycoplasma or Chlamydia, in children 6 months and older, with a dosage of 10 mg/kg (maximum 500 mg) on day 1, followed by 5 mg/kg (maximum 250 mg) daily for days 2-5 9, 10

Safety Considerations

• Azithromycin has fewer gastrointestinal side effects compared to other macrolides, such as erythromycin, according to the Centers for Disease Control and Prevention 7
• Common side effects of azithromycin include abdominal discomfort, diarrhea, nausea, vomiting, headache, and dizziness, as reported by the Centers for Disease Control and Prevention 7
• Azithromycin should not be taken simultaneously with aluminum or magnesium-containing antacids, as they reduce absorption, according to the Centers for Disease Control and Prevention 7
• Azithromycin is classified as an FDA Pregnancy Category B drug, according to the Centers for Disease Control and Prevention 7

Clinical Pearls

• For pertussis treatment and prophylaxis, azithromycin is preferred over erythromycin due to a better safety profile, especially in young infants, as recommended by the Centers for Disease Control and Prevention 7, 8
• In infants under 1 month, the risk of severe pertussis complications outweighs the potential risks of azithromycin treatment, according to the Centers for Disease Control and Prevention 7, 8

IV Azithromycin Dosing for Pediatric Patients

Standard IV Dosing Protocol

• The Infectious Diseases Society of America recommends administering 10 mg/kg of IV azithromycin once daily, with a maximum single dose of 500 mg, on days 1 and 2, then transitioning to oral therapy as soon as clinically feasible, for pediatric patients requiring intravenous azithromycin 11
• The duration of IV therapy is typically limited to days 1 and 2 of treatment, with transition to oral therapy when the patient can tolerate it, according to the Infectious Diseases Society of America 11

Indication-Specific Considerations

• For community-acquired pneumonia caused by atypical pathogens such as Mycoplasma pneumoniae, Chlamydia trachomatis, or Chlamydophila pneumoniae, IV azithromycin is the preferred agent when parenteral therapy is required, as recommended by the Infectious Diseases Society of America 11
• The 10 mg/kg IV dosing on days 1-2 applies, with early transition to oral therapy, for community-acquired pneumonia caused by atypical pathogens, according to the Infectious Diseases Society of America 11

Common Pitfalls to Avoid

• The Infectious Diseases Society of America recommends avoiding prolonged IV therapy beyond 2 days when oral therapy is feasible, and ensuring the full 10 mg/kg dose is given to prevent underdosing 11
• IV azithromycin is specifically indicated for atypical pathogens, and typical bacterial pneumonia requires beta-lactam antibiotics as first-line therapy, as recommended by the Infectious Diseases Society of America 11 and the American Academy of Pediatrics 12

Azithromycin Dosing for Pediatric Patients

Standard Dosing by Indication

• The Infectious Diseases Society of America and the American Academy of Pediatrics recommend a 5-day regimen of azithromycin for atypical pneumonia caused by Mycoplasma pneumoniae, Chlamydia pneumoniae, or Chlamydia trachomatis, with a dose of 10 mg/kg (max 500 mg) on day 1, then 5 mg/kg (max 250 mg) daily for days 2-5, with the caveat that azithromycin is not first-line for typical bacterial pneumonia caused by S. pneumoniae or H. influenzae, for which amoxicillin remains the preferred agent 13
• Azithromycin is second-line therapy for strep throat, with penicillin or amoxicillin remaining first-line, and a higher dose of 12 mg/kg once daily for 5 days (maximum 500 mg/day) is necessary due to high recurrence rates with the standard 10 mg/kg regimen 13

Azithromycin Dosing for Adolescents

Standard Dosing by Indication

• The Infectious Diseases Society of America recommends a preferred regimen of 10 mg/kg (maximum 500 mg) on day 1, then 5 mg/kg (maximum 250 mg) once daily for days 2-5 for respiratory tract infections, including community-acquired pneumonia and atypical pneumonia 14
• The American Academy of Pediatrics supports the use of a 5-day course of azithromycin for atypical pathogens, including Mycoplasma pneumoniae, Chlamydia pneumoniae, and Chlamydia trachomatis 14

Genital Chlamydial Infections

• The Centers for Disease Control and Prevention recommends a single 1 gram oral dose of azithromycin as the recommended treatment for uncomplicated urethritis or cervicitis caused by Chlamydia trachomatis 15

Maximum Doses

• The American College of Clinical Pharmacy advises that oral doses of azithromycin should never exceed adult doses, regardless of weight, with a maximum of 500 mg on day 1 and 250 mg daily for the 5-day respiratory regimen 14

Azithromycin Dosing Guidelines for Pediatric Patients

Indication-Specific Considerations

• For streptococcal pharyngitis, azithromycin is second-line therapy only, with penicillin or amoxicillin remaining first-line, according to the American Heart Association, as published in Circulation 16

Dosage and Administration

• No cited facts are available for this section

Azithromycin Dosing Guidelines for Upper Respiratory Tract Infections

Dosing Recommendations

• The Infectious Diseases Society of America (IDSA) recommends azithromycin 10 mg/kg (maximum 500 mg) on day 1, followed by 5 mg/kg (maximum 250 mg) daily for days 2-5, for a total 5-day course for pediatric patients with upper respiratory tract infections 17

Clinical Context and Indications

• Azithromycin is specifically indicated for atypical pathogens causing upper respiratory infections, including Mycoplasma pneumoniae, Chlamydia pneumoniae, and Chlamydia trachomatis, as recommended by the IDSA 17
• For typical bacterial pharyngitis (strep throat) or pneumonia caused by Streptococcus pneumoniae or Haemophilus influenzae, amoxicillin remains the first-line agent, not azithromycin, according to the IDSA 17

Expected Clinical Response

• Children on adequate azithromycin therapy should demonstrate clinical improvement within 48-72 hours, as reported in Clinical Infectious Diseases 17
• If the patient deteriorates or shows no improvement within this timeframe, further investigation is warranted, including assessment for complications such as parapneumonic effusion, as recommended by the IDSA 17

Administration of Azithromycin Formulations

Oral Suspension Formulation

• The pediatric oral suspension formulation is specifically designed to be reconstituted with water before administration, making it the preferred formulation for children who cannot swallow tablets, as recommended by guidelines from the American Academy of Pediatrics 18

Important Administration Considerations

• Do not administer azithromycin simultaneously with aluminum- or magnesium-containing antacids, as these reduce drug absorption and should be separated by at least 2 hours, according to the European Respiratory Society 18

Azithromycin Administration Guidelines

Intravenous and Oral Administration

• The Centers for Disease Control and Prevention recommends administering azithromycin at 1 mg/mL concentration over 3 hours OR 2 mg/mL concentration over 1 hour 19
• The MMWR Recommendations and Reports suggests administering azithromycin 1 hour before or 2 hours after meals, and separating its administration from aluminum- or magnesium-containing antacids by at least 2 hours 19
• The guideline recommends using caution in patients with hepatic impairment, as biliary excretion is the main route of elimination, with azithromycin undergoing primarily biliary excretion (approximately 6% appears unchanged in urine) 19

Safety and Adverse Effects

• The MMWR Recommendations and Reports reports common adverse effects of azithromycin, including gastrointestinal disturbances (abdominal discomfort, diarrhea, nausea, vomiting), dizziness, and headache 19
• The guideline also notes rare but serious adverse effects, such as acute interstitial nephritis, allergic reactions/anaphylaxis, and pseudomembranous colitis 19

Acute Otitis Media Treatment Recommendations for Adolescents

Introduction to Azithromycin

• The Centers for Disease Control and Prevention (CDC) recommends azithromycin as a preferred treatment option for adolescents with acute otitis media (AOM) due to its superior tolerance profile, simpler dosing regimen, and lower gastrointestinal side effects compared to erythromycin 20

Safety and Tolerance

• Azithromycin has significantly lower gastrointestinal side effects compared to erythromycin, including nausea, vomiting, abdominal pain, and diarrhea, as reported by the CDC 20
• The CDC also notes that azithromycin has a lower rate of premature therapy discontinuation due to adverse events compared to erythromycin 20

Dosage and Administration

• For adolescents with AOM, the recommended dosage of azithromycin is 500 mg on the first day, followed by 250 mg once daily on days 2-5, as suggested by guidelines based on evidence from the MMWR Recommendations and Reports 20
• If azithromycin is not available or contraindicated, erythromycin can be used at a dosage of 40-50 mg/kg/day divided into 4 doses for 14 days (maximum 2 grams/day), according to the CDC guidelines 20

Important Considerations

• Azithromycin should not be administered concurrently with antacids containing aluminum or magnesium, as this may reduce absorption; administration should be separated by at least 2 hours, as recommended by the CDC 20
• Monitoring is required when azithromycin is used concomitantly with drugs metabolized by the cytochrome P450 enzyme system, as advised by the CDC 20

Azithromycin Dosing Guidelines for Children

Weight-Based Dosing and Administration

• The British Thoracic Society guidelines recommend that children weighing 15-25 kg should receive 200 mg of azithromycin once daily, based on weight-band dosing guidelines, for a child weighing 18.69 kg 21
• Azithromycin can be taken with or without food, but should not be administered simultaneously with aluminum- or magnesium-containing antacids, and administration should be separated by at least 2 hours, as antacids reduce drug absorption 21

Monitoring and Safety Considerations

• The British Thoracic Society guidelines recommend obtaining baseline ECG, repeating at 2 weeks, and after adding any QT-prolonging medications, as azithromycin can prolong the QT interval, and performing baseline and intermittent audiometry during treatment, particularly with prolonged courses 21
• Laboratory monitoring, including liver function tests, renal function, and complete blood count, should be checked sporadically throughout treatment, as recommended by the British Thoracic Society guidelines 21

Azithromycin Use in Pediatric Respiratory Infections

Indication‑Specific Recommendations

• Azithromycin 10 mg/kg on day 1 followed by 5 mg/kg once daily on days 2‑5 is the standard 5‑day regimen for community‑acquired pneumonia in children; this schedule provides adequate tissue concentrations for treatment of atypical pathogens such as Mycoplasma pneumoniae, Chlamydia pneumoniae, and Chlamydia trachomatis【22】.

• Azithromycin is appropriate when atypical pathogens are suspected (e.g., M. pneumoniae, C. pneumoniae, C. trachomatis) or when the child has a documented allergy to β‑lactam antibiotics【22】.

• For typical bacterial pneumonia caused by Streptococcus pneumoniae or Haemophilus influenzae, amoxicillin at 90 mg/kg/day remains the first‑line therapy; azithromycin should not be used as monotherapy【22】.

Expected Clinical Response

• Children with appropriate indications should show clinical improvement within 48–72 hours after initiating azithromycin therapy【22】.

• If no improvement or clinical deterioration occurs within this 48–72‑hour window, clinicians should reassess the diagnosis, consider alternative pathogens, resistance patterns, or complications, and adjust therapy accordingly【22】.

Practical Guidance to Avoid Misuse

• Do not underdose the initial 10 mg/kg dose on day 1; full dosing is essential to achieve therapeutic tissue levels【22】.

• Do not prescribe azithromycin as first‑line treatment for typical bacterial pneumonia or streptococcal pharyngitis, as β‑lactam agents have superior outcomes and lower recurrence rates【22】.

Azithromycin Dosing Guidelines for Children (British Thoracic Society)

Weight‑Based Dosing

• For a 6‑year‑old child weighing 48 lb (≈21.8 kg), the recommended azithromycin dose is 200 mg once daily based on the British Thoracic Society weight‑band dosing guidelines. 23, 24
• The British Thoracic Society weight‑band algorithm assigns 200 mg once daily to the 15–25 kg weight band (which includes a 21.8 kg child). This derives from the standard pediatric calculation of 10 mg/kg once daily (maximum 500 mg per dose). 23, 24

Dosing by Weight Band (6 months – 17 years)

All values are taken from the British Thoracic Society dosing table. 23, 24

Administration Considerations

• Azithromycin must not be taken simultaneously with aluminum‑ or magnesium‑containing antacids; doses should be separated by at least 2 hours because antacids reduce azithromycin absorption. 23, 24

Monitoring for Prolonged Courses

• For extended therapy (e.g., non‑tuberculous mycobacterial infection), the British Thoracic Society recommends:

Safety Profile

• The most common adverse effects in children are gastrointestinal disturbances (abdominal discomfort, diarrhea, nausea, vomiting), dizziness, and headache. 23, 24

Evidence strength for the above recommendations was not explicitly graded in the source documents.

Azithromycin Use in Pediatric Community‑Acquired Pneumonia

Indication and Dosing in Children ≥ 6 Months

• The Clinical Infectious Diseases guideline (2011) confirms that azithromycin is safe and effective for treating community‑acquired pneumonia in children aged six months and older when dosed at 10 mg/kg on day 1 followed by 5 mg/kg daily on days 2–5 (maximum 500 mg on day 1, 250 mg on subsequent days)【25】.

First‑Line Therapy Recommendations

• According to the same guideline, azithromycin should not be used as first‑line therapy for typical bacterial pneumonia caused by Streptococcus pneumoniae or Haemophilus influenzae; the recommended first‑line agent is amoxicillin at 90 mg/kg/day【25】.

Reserved Indications

• The guideline advises that azithromycin be reserved for atypical pathogens (e.g., Mycoplasma pneumoniae, Chlamydia pneumoniae) or when a child has a documented penicillin allergy【25】.

Azithromycin Pediatric Dosing Guidelines (Cited Evidence)

Weight‑Band Dosing (British Thoracic Society)

The British Thoracic Society recommends a simplified once‑daily azithromycin regimen for children 6 months to 17 years, administered for 5 days.

This dosing strategy is intended to cover common atypical respiratory infections in the pediatric population. 26

Mycobacterium avium Complex (MAC) Prophylaxis in HIV‑Infected Children

For HIV‑infected children requiring MAC prophylaxis, the CDC (MMWR Recommendations and Reports) advises azithromycin 20 mg/kg given once weekly, with a maximum single dose of 1,200 mg. This weekly schedule is designed to maintain effective antimicrobial coverage while minimizing toxicity. 27

Azithromycin Dosing Recommendations in Children

Standard Dosing Regimens

• The Infectious Diseases Society of America and the American Academy of Pediatrics recommend a five‑day azithromycin regimen for community‑acquired pneumonia and atypical respiratory infections in children: Day 1 = 10 mg/kg (max 500 mg) once daily; Days 2‑5 = 5 mg/kg (max 250 mg) once daily. This schedule is strongly endorsed in the guideline 28.

Lack of Evidence for Twice‑Daily (BID) Dosing

• All major pediatric infectious‑disease guidelines—including those of the Infectious Diseases Society of America, the American Academy of Pediatrics, the Centers for Disease Control and Prevention, and the British Thoracic Society—do not support twice‑daily azithromycin dosing in children and uniformly recommend once‑daily administration. The recommendation is based on a lack of clinical‑trial or guideline evidence for BID dosing [29][30][31][28].

Exceptions for Other Macrolides

• Clarithromycin, a different macrolide, is dosed at 7.5 mg/kg twice daily in pediatric patients; this dosing should not be applied to azithromycin [29][28].

Special Indications (Once‑Daily Dosing)

• For prophylaxis against Mycobacterium avium complex in HIV‑infected children, the guideline advises 20 mg/kg once weekly (maximum 1,200 mg) 32.

Expected Clinical Response and Management of Non‑Response

• Children with appropriate infections should show clinical improvement within 48–72 hours of starting azithromycin; this timeframe is supported by guideline evidence 28.
• If no improvement occurs within this window, clinicians should reassess for:

Common Pitfalls and Administration Considerations

• Splitting the total daily azithromycin dose into twice‑daily administrations lacks evidence and may diminish tissue accumulation, contrary to the drug’s pharmacokinetic advantages; this practice is discouraged by the guideline 28.
• Azithromycin should not be confused with other macrolides that require more frequent dosing (e.g., clarithromycin or erythromycin), as azithromycin’s unique structure permits once‑daily dosing [29][28].

Guideline Recommendations for Azithromycin Use in Infants and Neonates

Neonatal ( < 1 month) Use

• The CDC recommends azithromycin as the preferred macrolide for pertussis treatment and post‑exposure prophylaxis in neonates, dosed at 10 mg/kg once daily for 5 days【33】.
• CDC states that, for pertussis, the risk of severe disease and life‑threatening complications outweighs the potential risk of infantile hypertrophic pyloric stenosis (IHPS) that has been linked to erythromycin【33】.
• Azithromycin has not been associated with IHPS in neonates, making it a safer macrolide choice compared with erythromycin【33】.
• Infants < 1 month receiving azithromycin should be monitored for signs of IHPS and other serious adverse events (e.g., non‑bilious projectile vomiting, visible peristaltic waves)【33】.
• CDC advises not to withhold azithromycin from neonates with pertussis exposure despite the lack of FDA licensure; the benefit‑risk assessment in CDC guidance supersedes the regulatory limitation【33】.

Infants 1–5 Months

• Azithromycin is recommended by CDC as a first‑line agent for pertussis treatment and prophylaxis in infants 1–5 months, using the same 10 mg/kg once‑daily for 5 days regimen【33】.
• Limited clinical data show microbiologic effectiveness against pertussis comparable to that in older children, supporting its use based on in‑vitro activity, demonstrated safety in older age groups, and convenient dosing【33】.

Infants ≥ 6 Months

• CDC notes that standard FDA‑approved dosing for children ≥ 6 months is 10 mg/kg (max 500 mg) on day 1, followed by 5 mg/kg (max 250 mg) once daily on days 2–5 for respiratory infections【33】.

Regulatory Context

• The FDA has not licensed any macrolide for infants < 6 months, but CDC guidance permits off‑label azithromycin use when clinically indicated, emphasizing that lack of licensure does not equal contraindication【33】.

Safety and Tolerability

• CDC reports that azithromycin is better tolerated than co‑amoxiclav and causes fewer gastrointestinal side effects than erythromycin in pediatric patients【33】.

Administration Considerations

• CDC advises separating azithromycin from aluminum‑ or magnesium‑containing antacids by at least 2 hours to avoid absorption interference【33】.
• The once‑daily dosing schedule of azithromycin is highlighted as a major advantage over erythromycin (four times daily) and clarithromycin (twice daily) for young children, improving adherence【33】.

Adult Dosing for Children ≥ 40 kg According to ATS/CDC/IDSA Tuberculosis Guidelines

Weight‑Based Dosing Thresholds

• The American Thoracic Society, CDC, and IDSA tuberculosis guideline recommends that children weighing more than 40 kg be dosed as adults, i.e., they should receive the standard adult azithromycin regimen (500 mg on day 1, then 250 mg daily on days 2–5) for respiratory infections. 34